Advanced glycation end product (AGE)-immunoreactive materials in chronic prurigo patients receiving a long-standing haemodialysis

British Journal of Dermatology

Volumn 150, Issue 4, 2004, Pages 757-760

  Fujimoto, N ^a   Tajima, S ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Advanced glycation end product; Chronic prurigo; Haemodialysis; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; ANEMIA; ARTICLE; CASE REPORT; CELL INFILTRATION; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GLYCATION; HEMODIALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERPHOSPHATEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY POLYCYSTIC DISEASE; LABORATORY DIAGNOSIS; LIVER FUNCTION; LONG TERM CARE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PRURIGO; SKIN BIOPSY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DERMIS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRURIGO; RENAL DIALYSIS;

EID: 2342514828     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0007-0963.2004.05864.x     Document Type: Article

References (20)

1. Jorizzo JL, Gatti S, Smith EB. Prurigo: a clinical review. J Am Acad Dermatol 1981; 4: 723-8.
2. Weisman K, Graham RM. Systemic diseases and the skin. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th edn. Oxford: Blackwell Science, 1998: 2728-31.
3. Gupta AK, Gupta MA, Cardella CJ et al. Cutaneous associations of chronic renal failure and dialysis. Int J Dermatol 1986; 25: 498-504.
4. Greer KE. Prurigo nodularis and uremia. South Med J 1975; 68: 138-41.
5. Brownlee M, Cerami A, Vlassara H. Advanced glycation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21.
6. Meng J, Sakata N, Imanaga Y et al. Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage. Nephron 2001; 88: 30-5.
7. Taneda S, Monnier VM. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 1994; 40: 1766-73.
8. Friedlander MA, Wu YC, Schulak JA et al. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995; 25: 445-51.
9. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991; 266: 7329-32.
10. Ikeda K, Higashi T, Sano H et al. N(epsilon)-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075-83.
11. ε-(carboxymethyl) lysine, one of the glycoxidation products of the Maillard reaction. J Invest Dermatol 1997; 108: 797-802.
12. Fujimoto N, Yajima M, Ohnishi Y et al. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosls. J Invest Dermatol 2002; 118: 479-84.
13. Miyata T, Oda O, Inagi R et al. Beta 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-52.
14. Sato KC, Kumakiri M, Koizumi H et al. Lichenoid skin lesions as a sign of beta 2-microglobulin-induced amyloidosis in a long-term haemodialysis patient. Br J Dermatol 1993; 128: 686-9.
15. Kirstein M, Brett J, Radoff S et al. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010-4.
16. Iida Y, Miyata T, Inagi R et al. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 1994; 201: 1235-41.
17. Miyata T, Iida Y, Ueda Y et al. Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products. Kidney Int 1996; 49: 538-50.
18. Horie K, Miyata T, Maeda K et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997; 100: 2995-3004.
19. Sell DR, Monnier VM. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990; 85: 380-4.
20. Holbrook KA, Wolff K. The structure and development of skin. In: Dermatology in General Medicine (Fitzpatrick TB, Einsen AZ, Freedberg IM, Frank Austen K, eds), 4th edn. New York: McGraw-Hill, Inc., 1993; 97-145.